Literature DB >> 22811574

Variants of stretch-activated two-pore potassium channel TREK-1 associated with preterm labor in humans.

Yi-Ying Wu1, Cherie A Singer, Iain L O Buxton.   

Abstract

Spontaneous preterm labor (PTL) is a uniquely human problem that results in preterm delivery of an underdeveloped fetus. The underlying cause remains elusive. The cost to societies in human suffering and treasure is enormous. The stretch-activated two pore potassium channel TREK-1 is up-regulated during gestation to term such that it may maintain uterine quiescence by hyperpolarizing the smooth muscle cell membrane. We have hypothesized that the human TREK-1 channel is involved in myometrial relaxation during pregnancy and that splice variants of the TREK-1 channel expressed in preterm myometrium are associated with preterm delivery by interaction with full-length TREK-1. We detected three wild-type human TREK-1 transcript isoforms in nonpregnant and pregnant human myometrium. Using RT-PCR, we identified five unique TREK-1 splice variants in myometrium from women in PTL. These myometrial TREK-1 variants lack either the pore or the transmembrane domains or both. In transiently transfected HEK293T cells, wild-type TREK-1 was predominantly expressed at the plasma membrane. However, individual splice variants were expressed uniformly throughout the cell. Wild-type TREK-1 was localized at the plasma membrane and cytoplasm close to the plasma membrane when coexpressed with each splice variant. Co-immunoprecipitation of FLAG epitope-tagged TREK-1 and six-His epitope-tagged splice variants using Ni bead columns successfully pulled down wild-type TREK-1. These results suggest that each of four TREK-1 splice variants interacts with full-length wild-type TREK-1 and that in vivo, such interactions may contribute to a PTL phenotype.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22811574      PMCID: PMC3507547          DOI: 10.1095/biolreprod.112.099499

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  21 in total

1.  Expression of stretch-activated potassium channels in human myometrium.

Authors:  Jennifer N Tichenor; Eric T Hansen; Iain L O Buxton
Journal:  Proc West Pharmacol Soc       Date:  2005

2.  Alternative translation initiation in rat brain yields K2P2.1 potassium channels permeable to sodium.

Authors:  Dierk Thomas; Leigh D Plant; Christina M Wilkens; Zoe A McCrossan; Steve A N Goldstein
Journal:  Neuron       Date:  2008-06-26       Impact factor: 17.173

Review 3.  Progestin treatment for the prevention of preterm birth.

Authors:  Miha Lucovnik; Ruben J Kuon; Linda R Chambliss; William L Maner; Shao-Qing Shi; Leili Shi; James Balducci; Robert E Garfield
Journal:  Acta Obstet Gynecol Scand       Date:  2011-06-27       Impact factor: 3.636

4.  Expression of TASK and TREK, two-pore domain K+ channels, in human myometrium.

Authors:  Xilian Bai; George J Bugg; Susan L Greenwood; Jocelyn D Glazier; Colin P Sibley; Philip N Baker; Michael J Taggart; Gregor K Fyfe
Journal:  Reproduction       Date:  2005-04       Impact factor: 3.906

5.  cAMP analogs and their metabolites enhance TREK-1 mRNA and K+ current expression in adrenocortical cells.

Authors:  Judith A Enyeart; Haiyan Liu; John J Enyeart
Journal:  Mol Pharmacol       Date:  2009-12-22       Impact factor: 4.436

6.  The stretch-activated potassium channel TREK-1 in rat cardiac ventricular muscle.

Authors:  Vitaly Dyachenko; Marylou Zuzarte; Caroline Putzke; Regina Preisig-Müller; Gerrit Isenberg; Jürgen Daut
Journal:  Cardiovasc Res       Date:  2005-10-24       Impact factor: 10.787

Review 7.  The mechano-gated K(2P) channel TREK-1.

Authors:  Alexandra Dedman; Reza Sharif-Naeini; Joost H A Folgering; Fabrice Duprat; Amanda Patel; Eric Honoré
Journal:  Eur Biophys J       Date:  2008-03-28       Impact factor: 1.733

8.  The presence of arachidonic acid-activated K+ channel, TREK-1, in human periodontal ligament fibroblasts.

Authors:  Yukikazu Saeki; Akito Ohara; Masanori Nishikawa; Takahiro Yamamoto; Gaku Yamamoto
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

9.  Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel.

Authors:  Nicolas Blondeau; Olivier Pétrault; Stella Manta; Valérie Giordanengo; Pierre Gounon; Régis Bordet; Michel Lazdunski; Catherine Heurteaux
Journal:  Circ Res       Date:  2007-06-07       Impact factor: 17.367

10.  Up- and down-regulation of the mechano-gated K(2P) channel TREK-1 by PIP (2) and other membrane phospholipids.

Authors:  Jean Chemin; Amanda Jane Patel; Fabrice Duprat; Frederick Sachs; Michel Lazdunski; Eric Honore
Journal:  Pflugers Arch       Date:  2007-03-24       Impact factor: 4.458

View more
  13 in total

Review 1.  Temperature sensitivity of two-pore (K2P) potassium channels.

Authors:  Eve R Schneider; Evan O Anderson; Elena O Gracheva; Sviatoslav N Bagriantsev
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

2.  TREK-1 currents in smooth muscle cells from pregnant human myometrium.

Authors:  Nathanael S Heyman; Chad L Cowles; Scott D Barnett; Yi-Ying Wu; Charles Cullison; Cherie A Singer; Normand Leblanc; Iain L O Buxton
Journal:  Am J Physiol Cell Physiol       Date:  2013-06-26       Impact factor: 4.249

Review 3.  Diversity of potassium channels in human umbilical artery smooth muscle cells: a review of their roles in human umbilical artery contraction.

Authors:  Pedro Martín; Alejandro Rebolledo; Ana Rocio Roldán Palomo; Melisa Moncada; Luciano Piccinini; Verónica Milesi
Journal:  Reprod Sci       Date:  2013-09-30       Impact factor: 3.060

4.  β(IV)-Spectrin regulates TREK-1 membrane targeting in the heart.

Authors:  Thomas J Hund; Jedidiah S Snyder; Xiangqiong Wu; Patric Glynn; Olha M Koval; Birce Onal; Nicholas D Leymaster; Sathya D Unudurthi; Jerry Curran; Celia Camardo; Patrick J Wright; Philip F Binkley; Mark E Anderson; Peter J Mohler
Journal:  Cardiovasc Res       Date:  2014-01-20       Impact factor: 10.787

5.  P2Y receptor regulation of K2P channels that facilitate K+ secretion by human mammary epithelial cells.

Authors:  Yotesawee Srisomboon; Nathan A Zaidman; Peter J Maniak; Chatsri Deachapunya; Scott M O'Grady
Journal:  Am J Physiol Cell Physiol       Date:  2018-01-24       Impact factor: 4.249

6.  Adaptive reduction of human myometrium contractile activity in response to prolonged uterine stretch during term and twin pregnancy. Role of TREK-1 channel.

Authors:  Zongzhi Yin; Wenzhu He; Yun Li; Dan Li; Hongyan Li; Yuanyuan Yang; Zhaolian Wei; Bing Shen; Xi Wang; Yunxia Cao; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-03-22       Impact factor: 5.858

7.  Response of the human detrusor to stretch is regulated by TREK-1, a two-pore-domain (K2P) mechano-gated potassium channel.

Authors:  Qi Lei; Xiao-Qing Pan; Shaohua Chang; S Bruce Malkowicz; Thomas J Guzzo; Anna P Malykhina
Journal:  J Physiol       Date:  2014-05-06       Impact factor: 5.182

8.  A splice variant of the two-pore domain potassium channel TREK-1 with only one pore domain reduces the surface expression of full-length TREK-1 channels.

Authors:  Susanne Rinné; Vijay Renigunta; Günter Schlichthörl; Marylou Zuzarte; Stefan Bittner; Sven G Meuth; Niels Decher; Jürgen Daut; Regina Preisig-Müller
Journal:  Pflugers Arch       Date:  2013-11-07       Impact factor: 3.657

9.  Alternatively Spliced Human TREK-1 Variants Alter TREK-1 Channel Function and Localization.

Authors:  Chad L Cowles; Yi-Ying Wu; Scott D Barnett; Michael T Lee; Heather R Burkin; Iain L O Buxton
Journal:  Biol Reprod       Date:  2015-09-23       Impact factor: 4.285

10.  TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.

Authors:  Jérôme Busserolles; Ismail Ben Soussia; Laetitia Pouchol; Nicolas Marie; Mathieu Meleine; Maïly Devilliers; Céline Judon; Julien Schopp; Loïc Clémenceau; Laura Poupon; Eric Chapuy; Serge Richard; Florence Noble; Florian Lesage; Sylvie Ducki; Alain Eschalier; Stéphane Lolignier
Journal:  Br J Pharmacol       Date:  2020-09-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.